MEDLEY (TSE:4480) EBIT: 円2,553 Mil (TTM As of Dec. 2025)


TSE:4480 MEDLEY Inc TSE:4480
71 GF Score
Price 円1,980.00
GF Value 円6,724.37
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is MEDLEY EBIT?

MEDLEY TSE:4480 -0.85% 71 EBIT is 円2,553 Mil as of Dec. 2025. GuruFocus rates TSE:4480 with a GF Score™ of 71/100 and a GF Value™ of 円6,724.37 (Significantly Undervalued). The stock has 4 warning signs investors should review.

MEDLEY's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2025 was 円561 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was 円2,553 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. MEDLEY's annualized ROC % for the quarter that ended in Dec. 2025 was 0.00%. MEDLEY's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 358.47%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. MEDLEY's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 3.81%.


MEDLEY  (TSE:4480) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

MEDLEY's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=2152 * ( 1 - 100% )/( (35300 + 34691)/ 2 )
=0/34995.5
=0.00 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

MEDLEY's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2244/( ( (643 + max(-3483, 0)) + (609 + max(-1485, 0)) )/ 2 )
=2244/( ( 643 + 609 )/ 2 )
=2244/626
=358.47 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2877 + 512 + 600) - (3081 + 0 + 4391)
=-3483

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4923 + 604 + 718) - (3257 + 0 + 4473)
=-1485

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

MEDLEY's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=2553/67000.894
=3.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MEDLEY EBIT Related Terms


MEDLEY EBIT Historical Data

* Premium members only.

The historical data trend for MEDLEY's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MEDLEY EBIT Chart

MEDLEY Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial 782.00 1,534.00 3,813.00 4,135.00 2,553.00

MEDLEY Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 365.00 248.00 1,619.00 125.00 561.00

TSE:4480 vs VEEV, BTSG, TEM: EBIT Comparison

For the Health Information Services subindustry, MEDLEY's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MEDLEY EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MEDLEY's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MEDLEY's EV-to-EBIT falls into.


TSE:4480
71GF Score
MEDLEY Inc TSE:4480
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MEDLEY EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,553 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of 円2,553 Mil mean?
MEDLEY (TSE:4480) has a EBIT of 円2,553 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on MEDLEY.
Is MEDLEY's EBIT too high?
MEDLEY's current EBIT is 円2,553 Mil. Overall, MEDLEY has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MEDLEY's EBIT compare to VEEV and BTSG?
MEDLEY's EBIT of 円2,553 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on MEDLEY. MEDLEY's current EBIT is 円2,553 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDLEY stock overvalued right now?
Based on GuruFocus' analysis, MEDLEY (TSE:4480) is currently considered Significantly Undervalued. The stock's GF Value™ is 円6,724.37, compared to a current price of 円1,980.00 — trading 70.6% below its estimated fair value. The current EBIT is 円2,553 Mil. MEDLEY's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For MEDLEY (TSE:4480), the current EBIT is 円2,553 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MEDLEY (TSE:4480) Overvalued in 2026?

Based on GuruFocus' analysis, MEDLEY stock appears to be undervalued. The current stock price of 円1,980.00 is trading 70.6% below its estimated GF Value™ of 円6,724.37. GuruFocus considers MEDLEY to be Significantly Undervalued.

Key valuation signals for TSE:4480:

  • EBIT: 円2,553 Mil
  • GF Value™: 円6,724.37 vs. price of 円1,980.00 (70.6% below fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the TSE:4480 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MEDLEY Business Description

Other Exchanges MDLYF:USA3YV:Germany
Address 3-2-1 Roppongi, Minato-ku, 22nd Floor Sumitomo Fudosan Roppongi Grand Tower, Tokyo, JPN, 106-6222
MEDLEY Inc is engaged in providing medical information service for patients, and nursing care, a nursing care information service for citizens resolving issues in the field of medical healthcare. It provides its services through two platforms, Recruitment Platform Business which provides human resource recruitment systems in the medical and healthcare field and related businesses; and Medical Platform Business that is a telemedicine system for both patients and medical institutions.
71GF Score

Get the complete analysis for TSE:4480

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,980.00
Price
円6,724.37
GF Value